ISLAMABAD: Special Assistant to the Prime Minister on National Health Services Dr Zafar Mirza has Wednesday warned that Dexamethasone, which showed positive results in UK, is only for critically ill COVID-19 patients.
The SAPM tweeted, “Positive results from UK on use of Dexamethasonein critical patients welcomed by WHO as a 1st treatment to be shown to reduce mortality in patients with COVID-19 requiring Oxygen or ventilator support. Expert Committee in Pakistan to consider inclusion.”
WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19…
The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are criticaly serious.
Dr Zafar Mirza further added, “It is an old & cheap anti-inflammatory medicine (steroid) & we have multiple producers in Pakistan.”
Positive results from UK on use of Dexamethaone in critical patients welcomed by WHO as a 1st treatment to be shown to reduce mortality in patients with COVID-19 requiring Oxygen or ventilator support. Expert Committee in 🇵🇰 to consider inclusion. https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients.
Read more: Smart lockdown imposed in 61 areas of Lahore to counter COVID-19
